Literature DB >> 31377829

Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis.

Nada Mahmoud Shresher1, Aly Elsayed Mohamed2, Mohsen Hassan Elshahaly3.   

Abstract

Fibromyalgia (FM) is a common comorbidity in rheumatoid arthritis (RA). Recently, there were several updates for the American College of Rheumatology (ACR) FM criteria. To assess the performance of the 2016 revised ACR FM criteria in patients with RA in comparison to 1990 criteria and to study the relation to composite disease measures. This study included 130 adult RA patients fulfilling the 2010 ACR/EULAR classification criteria for RA. Patients were evaluated according to 2016 and 1990 ACR criteria for FM. Kappa agreement between the two criteria was determined. Spearman's correlation between the polysymptomatic distress scale (PSD) and selected variables including disease activity score-28 with erythrocyte sedimentation rate (DAS-28 ESR), clinical disease activity index (CDAI), patient global assessment (PGA), and visual analogue scale (VAS) for pain was evaluated. Of the 130 RA patients, 52 patients (40%) satisfied the 2016 criteria and 40 (31.5%) the 1990 criteria. The Kappa agreement between the two criteria was 0.733. RA patients with FM had higher DAS28-ESR, CDAI, PGA, and VAS compared with those without FM. A significant positive correlation was found between the polysymptomatic Distress scale (PSD) and DAS28-ESR, CDAI, and PGA (rs 0.481, 0.516, 0.511, respectively, P < 0.001). FM coexists in a substantial number of RA patients according to the 2016 revised criteria and associated with high composite disease activity measures. Therefore, assessment of FM should be considered in RA patients with persistently high disease activity.

Entities:  

Keywords:  Fibromyalgia; Polysymptomatic distress; Prevalence; Rheumatoid arthritis

Mesh:

Year:  2019        PMID: 31377829     DOI: 10.1007/s00296-019-04403-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  45 in total

1.  Biostatistics 104: correlational analysis.

Authors:  Y H Chan
Journal:  Singapore Med J       Date:  2003-12       Impact factor: 1.858

2.  Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis.

Authors:  Varun Dhir; Able Lawrence; Amita Aggarwal; Ramnath Misra
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

3.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Authors:  Robert M Bennett; Ronald Friend; Kim D Jones; Rachel Ward; Bobby K Han; Rebecca L Ross
Journal:  Arthritis Res Ther       Date:  2009-08-10       Impact factor: 5.156

4.  Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management.

Authors:  Fabienne Coury; Arnaud Rossat; Alexandre Tebib; Marie-Claude Letroublon; Anne Gagnard; Bruno Fantino; Jacques G Tebib
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

5.  Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.

Authors:  Aline Ranzolin; João Carlos Tavares Brenol; Markus Bredemeier; Jairo Guarienti; Marcele Rizzatti; Daniel Feldman; Ricardo Machado Xavier
Journal:  Arthritis Rheum       Date:  2009-06-15

6.  Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in rheumatoid arthritis patients.

Authors:  Yasser M El Meidany; Maha M El Gaafary; Ihab Ahmed
Journal:  Joint Bone Spine       Date:  2003-06       Impact factor: 4.929

7.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

Review 8.  Sex, gender, and pain: a review of recent clinical and experimental findings.

Authors:  Roger B Fillingim; Christopher D King; Margarete C Ribeiro-Dasilva; Bridgett Rahim-Williams; Joseph L Riley
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

9.  The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

Authors:  Bonnie Bruce; James F Fries
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

10.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Authors:  Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

View more
  3 in total

1.  Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis.

Authors:  Lulu Si; Yunyan Jin; Dongni Zhao; Lixia Yu; Huankun Cao
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

Review 2.  Beyond Rheumatoid Arthritis Evaluation: What are We Missing?

Authors:  Gianna Espinoza; Genessis Maldonado; Jemina Narvaez; Roberto Guerrero; Gustavo Citera; Carlos Rios
Journal:  Open Access Rheumatol       Date:  2021-03-25

3.  Fibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis.

Authors:  Beth I Wallace; Meriah N Moore; Andrew C Heisler; Lutfiyya N Muhammad; Jing Song; Daniel J Clauw; Clifton O Bingham; Marcy B Bolster; Wendy Marder; Tuhina Neogi; Alyssa Wohlfahrt; Dorothy D Dunlop; Yvonne C Lee
Journal:  Rheumatology (Oxford)       Date:  2022-04-11       Impact factor: 7.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.